ロード中...
Immunotherapies in ovarian cancer
Ovarian cancer is the leading cause of death for gynaecological cancer, and new therapies are urgently awaited. Although the presence of tumour-infiltrating lymphocytes has been confirmed to be associated to a better prognosis, immunotherapy is not yet incorporated to the armamentarium in ovarian ca...
保存先:
| 出版年: | EJC Suppl |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573463/ https://ncbi.nlm.nih.gov/pubmed/33240447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2020.02.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|